Back to stocks
KLRA

KLRA

Kailera Therapeutics, Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
18
Partial Q3 2026
Total 13F value
$5.3M
Filed positions so far
New positions
11
This quarter
Sold positions
2
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Exchange Traded Concepts, Llc

$3M260.8K0.01%+71.0%

Y-Intercept (Hong Kong) Ltd

$790K69.2K0.02%New Position

Mirador Capital Partners Lp

$666K58.3K0.08%New Position

Profund Advisors Llc

$216K18.9K0.01%New Position

Tema Etfs Llc

$159K13.9K0.01%-0.7%

Strs Ohio

$144K12.6K0.00%+40.0%

Commonwealth Equity Services, Llc

$134K11.7K0.00%New Position

Principal Financial Group Inc

$121K10.6K0.00%New Position

Sterling Capital Management Llc

$15K1.3K0.00%+230.1%

Versant Capital Management, Inc

$14K1.2K0.00%New Position

Nisa Investment Advisors, Llc

$12K1.1K0.00%+21.1%

Caitong International Asset Management Co., Ltd

$11K9570.00%+4685.0%

Farther Finance Advisors, Llc

$1K900.00%New Position

Ifp Advisors, Inc

$548480.00%New Position

Gamma Investing Llc

$388340.00%New Position

Sjs Investment Consulting Inc.

$8070.00%New Position

Sbi Securities Co., Ltd.

$1110.00%Unchanged

Covestor Ltd

$0180.00%New Position

Explore